

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of glucokinase activity (GO:0033131) | 4.87426935 |
| 2 | regulation of hexokinase activity (GO:1903299) | 4.87426935 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.10542536 |
| 4 | inositol phosphate catabolic process (GO:0071545) | 4.07855576 |
| 5 | positive regulation of glycolytic process (GO:0045821) | 4.07055519 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.92179178 |
| 7 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.91197942 |
| 8 | positive regulation of protein autophosphorylation (GO:0031954) | 3.89618666 |
| 9 | keratinocyte development (GO:0003334) | 3.84822889 |
| 10 | protein K11-linked deubiquitination (GO:0035871) | 3.84445502 |
| 11 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.81411572 |
| 12 | regulation of protein glycosylation (GO:0060049) | 3.68967804 |
| 13 | polyol catabolic process (GO:0046174) | 3.63916272 |
| 14 | ketone body metabolic process (GO:1902224) | 3.63612572 |
| 15 | signal peptide processing (GO:0006465) | 3.63260597 |
| 16 | cellular ketone body metabolic process (GO:0046950) | 3.59468800 |
| 17 | inositol phosphate dephosphorylation (GO:0046855) | 3.55465509 |
| 18 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.55465509 |
| 19 | synapsis (GO:0007129) | 3.50466554 |
| 20 | parental behavior (GO:0060746) | 3.45630614 |
| 21 | platelet dense granule organization (GO:0060155) | 3.43153269 |
| 22 | protein prenylation (GO:0018342) | 3.33595254 |
| 23 | prenylation (GO:0097354) | 3.33595254 |
| 24 | lactate metabolic process (GO:0006089) | 3.33274303 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33213803 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33213803 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33213803 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.33213803 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33213803 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 3.33213803 |
| 31 | response to pheromone (GO:0019236) | 3.29000415 |
| 32 | nitric oxide mediated signal transduction (GO:0007263) | 3.28251029 |
| 33 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.27545362 |
| 34 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.27512081 |
| 35 | cornea development in camera-type eye (GO:0061303) | 3.17894883 |
| 36 | macroautophagy (GO:0016236) | 3.16700606 |
| 37 | regulation of meiosis I (GO:0060631) | 3.14316661 |
| 38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.14076963 |
| 39 | L-fucose catabolic process (GO:0042355) | 3.12287770 |
| 40 | fucose catabolic process (GO:0019317) | 3.12287770 |
| 41 | L-fucose metabolic process (GO:0042354) | 3.12287770 |
| 42 | negative regulation of lipid storage (GO:0010888) | 3.10870009 |
| 43 | negative regulation of complement activation (GO:0045916) | 3.10054394 |
| 44 | insulin secretion (GO:0030073) | 3.08477022 |
| 45 | response to lipoprotein particle (GO:0055094) | 3.04424163 |
| 46 | endocrine pancreas development (GO:0031018) | 3.03973181 |
| 47 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.00236332 |
| 48 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.00207542 |
| 49 | protein localization to Golgi apparatus (GO:0034067) | 2.99167053 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 2.89923771 |
| 51 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.89163184 |
| 52 | regulation of protein autophosphorylation (GO:0031952) | 2.88357604 |
| 53 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.85608164 |
| 54 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.85418909 |
| 55 | microglial cell activation (GO:0001774) | 2.84327267 |
| 56 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.82645390 |
| 57 | neural tube formation (GO:0001841) | 2.80144674 |
| 58 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.78751503 |
| 59 | negative regulation of neurological system process (GO:0031645) | 2.78071204 |
| 60 | positive regulation of meiosis (GO:0045836) | 2.75427702 |
| 61 | negative regulation of protein activation cascade (GO:2000258) | 2.71780812 |
| 62 | phospholipid homeostasis (GO:0055091) | 2.68876077 |
| 63 | positive regulation of meiotic cell cycle (GO:0051446) | 2.68670646 |
| 64 | positive regulation of macroautophagy (GO:0016239) | 2.67083995 |
| 65 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.66052709 |
| 66 | proline transport (GO:0015824) | 2.65667246 |
| 67 | zinc ion transport (GO:0006829) | 2.64432178 |
| 68 | regulation of glycolytic process (GO:0006110) | 2.62794627 |
| 69 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.61524347 |
| 70 | Golgi to endosome transport (GO:0006895) | 2.60437531 |
| 71 | negative regulation of acute inflammatory response (GO:0002674) | 2.59965436 |
| 72 | regulation of protein polyubiquitination (GO:1902914) | 2.59431638 |
| 73 | L-amino acid import (GO:0043092) | 2.58990155 |
| 74 | granulocyte activation (GO:0036230) | 2.58436670 |
| 75 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.57697896 |
| 76 | negative regulation of protein oligomerization (GO:0032460) | 2.57376029 |
| 77 | piRNA metabolic process (GO:0034587) | 2.56162204 |
| 78 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.56037712 |
| 79 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.56037712 |
| 80 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.56037712 |
| 81 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.55422086 |
| 82 | neutrophil activation (GO:0042119) | 2.53502075 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 2.51564456 |
| 84 | magnesium ion transport (GO:0015693) | 2.49615535 |
| 85 | ER overload response (GO:0006983) | 2.49116909 |
| 86 | macrophage activation (GO:0042116) | 2.47709768 |
| 87 | import into cell (GO:0098657) | 2.47388446 |
| 88 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.47146359 |
| 89 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.46013107 |
| 90 | regulation of Rac protein signal transduction (GO:0035020) | 2.45493226 |
| 91 | protein targeting to Golgi (GO:0000042) | 2.45289031 |
| 92 | inositol phosphate-mediated signaling (GO:0048016) | 2.44582747 |
| 93 | positive regulation of actin filament depolymerization (GO:0030836) | 2.44361827 |
| 94 | iron ion import (GO:0097286) | 2.43698073 |
| 95 | growth hormone receptor signaling pathway (GO:0060396) | 2.42908553 |
| 96 | xenobiotic catabolic process (GO:0042178) | 2.42867978 |
| 97 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.42588404 |
| 98 | DNA deamination (GO:0045006) | 2.42470161 |
| 99 | indole-containing compound catabolic process (GO:0042436) | 2.42402818 |
| 100 | indolalkylamine catabolic process (GO:0046218) | 2.42402818 |
| 101 | tryptophan catabolic process (GO:0006569) | 2.42402818 |
| 102 | protein localization to cilium (GO:0061512) | 2.42147497 |
| 103 | negative regulation of protein autophosphorylation (GO:0031953) | 2.42140446 |
| 104 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.40828765 |
| 105 | pancreas development (GO:0031016) | 2.40520336 |
| 106 | myeloid cell activation involved in immune response (GO:0002275) | 2.39859169 |
| 107 | respiratory burst (GO:0045730) | 2.39634248 |
| 108 | positive regulation of insulin secretion (GO:0032024) | 2.38775204 |
| 109 | I-kappaB phosphorylation (GO:0007252) | 2.38770554 |
| 110 | cellular response to ethanol (GO:0071361) | 2.37366111 |
| 111 | regulation of DNA endoreduplication (GO:0032875) | 2.35092766 |
| 112 | regulation of neurotransmitter uptake (GO:0051580) | 2.34405151 |
| 113 | cilium morphogenesis (GO:0060271) | 2.34330076 |
| 114 | endosome to pigment granule transport (GO:0043485) | 2.34115998 |
| 115 | endosome to melanosome transport (GO:0035646) | 2.34115998 |
| 116 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.33842576 |
| 117 | negative regulation of mast cell activation (GO:0033004) | 2.33677917 |
| 118 | thyroid hormone metabolic process (GO:0042403) | 2.33586877 |
| 119 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.33542307 |
| 120 | brain morphogenesis (GO:0048854) | 2.33044424 |
| 121 | regulation of carbohydrate catabolic process (GO:0043470) | 2.32402303 |
| 122 | regulation of cellular carbohydrate catabolic process (GO:0043471) | 2.32402303 |
| 123 | fibroblast migration (GO:0010761) | 2.32042238 |
| 124 | kidney morphogenesis (GO:0060993) | 2.31311748 |
| 125 | anterograde synaptic vesicle transport (GO:0048490) | 2.31262688 |
| 126 | positive regulation of peptide hormone secretion (GO:0090277) | 2.31259024 |
| 127 | astrocyte differentiation (GO:0048708) | 2.31019912 |
| 128 | axoneme assembly (GO:0035082) | 2.30749400 |
| 129 | regulation of sequestering of triglyceride (GO:0010889) | 2.29607677 |
| 130 | cholesterol efflux (GO:0033344) | 2.29337761 |
| 131 | superoxide anion generation (GO:0042554) | 2.26264346 |
| 132 | regulation of lipoprotein metabolic process (GO:0050746) | 2.25581575 |
| 133 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.24829166 |
| 134 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.24097772 |
| 135 | lipoprotein transport (GO:0042953) | 2.23247622 |
| 136 | establishment of protein localization to Golgi (GO:0072600) | 2.22274022 |
| 137 | glycosphingolipid catabolic process (GO:0046479) | 2.21784200 |
| 138 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.21383111 |
| 139 | positive regulation of p38MAPK cascade (GO:1900745) | 2.20162439 |
| 140 | early endosome to late endosome transport (GO:0045022) | 2.19844538 |
| 141 | protein localization to endosome (GO:0036010) | 2.19628818 |
| 142 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.18139646 |
| 143 | T-helper 1 type immune response (GO:0042088) | 2.17381653 |
| 144 | eosinophil chemotaxis (GO:0048245) | 2.17227886 |
| 145 | positive regulation of heat generation (GO:0031652) | 2.16480249 |
| 146 | tyrosine metabolic process (GO:0006570) | 2.15065970 |
| 147 | Rap protein signal transduction (GO:0032486) | 2.14598314 |
| 148 | neutrophil mediated immunity (GO:0002446) | 2.13262691 |
| 149 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.12184080 |
| 150 | response to host immune response (GO:0052572) | 2.11755732 |
| 151 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.11755732 |
| 152 | regulation of heat generation (GO:0031650) | 2.10264943 |
| 153 | regulation of activation of Janus kinase activity (GO:0010533) | 2.10072438 |
| 154 | sequestering of metal ion (GO:0051238) | 2.09790272 |
| 155 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.09318115 |
| 156 | protein carboxylation (GO:0018214) | 2.09318115 |
| 157 | developmental pigmentation (GO:0048066) | 2.09184863 |
| 158 | glycosylceramide metabolic process (GO:0006677) | 2.09120079 |
| 159 | prostate gland growth (GO:0060736) | 2.09042022 |
| 160 | cellular response to growth hormone stimulus (GO:0071378) | 2.06630459 |
| 161 | phagosome maturation (GO:0090382) | 2.06223445 |
| 162 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.06141622 |
| 163 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.05986673 |
| 164 | intracellular pH reduction (GO:0051452) | 2.05964842 |
| 165 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.05388357 |
| 166 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.04535018 |
| 167 | negative regulation of neurotransmitter transport (GO:0051589) | 2.03992308 |
| 168 | amino acid import (GO:0043090) | 2.03680989 |
| 169 | low-density lipoprotein particle clearance (GO:0034383) | 2.03506449 |
| 170 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.02958848 |
| 171 | regulation of mononuclear cell migration (GO:0071675) | 2.02517309 |
| 172 | regulation of mast cell degranulation (GO:0043304) | 2.01932077 |
| 173 | plasma lipoprotein particle clearance (GO:0034381) | 2.01148412 |
| 174 | regulation of energy homeostasis (GO:2000505) | 2.00118124 |
| 175 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.99686469 |
| 176 | positive regulation of muscle hypertrophy (GO:0014742) | 1.96151448 |
| 177 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 1.96151448 |
| 178 | regulation of cholesterol storage (GO:0010885) | 1.96058488 |
| 179 | nerve growth factor signaling pathway (GO:0038180) | 1.95233717 |
| 180 | regulation of beta-amyloid formation (GO:1902003) | 1.94404657 |
| 181 | glycolipid catabolic process (GO:0019377) | 1.94342884 |
| 182 | detection of molecule of bacterial origin (GO:0032490) | 1.93086796 |
| 183 | regulation of fever generation (GO:0031620) | 1.92957162 |
| 184 | regulation of mast cell activation (GO:0033003) | 1.92636513 |
| 185 | regulation of lipid storage (GO:0010883) | 1.92275721 |
| 186 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 1.92079457 |
| 187 | positive regulation of interferon-alpha production (GO:0032727) | 1.91113001 |
| 188 | regulation of cellular amide metabolic process (GO:0034248) | 1.90801967 |
| 189 | regulation of leukocyte degranulation (GO:0043300) | 1.88486553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.92907915 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.52180037 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.49543953 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.49171767 |
| 5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.45857957 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.37241580 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.34599953 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.33913637 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.22039950 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.19623496 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.16073425 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15212054 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08327595 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.05613798 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.03834647 |
| 16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.90827917 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90564501 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86478002 |
| 19 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.79527557 |
| 20 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.79527557 |
| 21 | EWS_26573619_Chip-Seq_HEK293_Human | 1.75610775 |
| 22 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.71382970 |
| 23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71245473 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62777484 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62698589 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59247726 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56228368 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53527382 |
| 29 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51666815 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51607783 |
| 31 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49903946 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48163584 |
| 33 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47555173 |
| 34 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47555173 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47443946 |
| 36 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47245799 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.47137857 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46509105 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45430076 |
| 40 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.45290853 |
| 41 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44713740 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44297848 |
| 43 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.41239072 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37048086 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36314521 |
| 46 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.36300843 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36104281 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33735020 |
| 49 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.33508153 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32779642 |
| 51 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32758769 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31722945 |
| 53 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.30416746 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29995889 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29625171 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29216184 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28795814 |
| 58 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28435597 |
| 59 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.27608536 |
| 60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26900412 |
| 61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26594293 |
| 62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.26389622 |
| 63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.25111283 |
| 64 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23988314 |
| 65 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23944803 |
| 66 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21832311 |
| 67 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21832311 |
| 68 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21556353 |
| 69 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21322286 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21007017 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.20959398 |
| 72 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20664341 |
| 73 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20628849 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19931064 |
| 75 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19895194 |
| 76 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.17901106 |
| 77 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.17709495 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17229368 |
| 79 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16593203 |
| 80 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.15976503 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15560694 |
| 82 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15300249 |
| 83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14035506 |
| 84 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.13469322 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12829802 |
| 86 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12739332 |
| 87 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12610044 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11799723 |
| 89 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.11762455 |
| 90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08905990 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08267410 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07959078 |
| 93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07945869 |
| 94 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07599433 |
| 95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07521832 |
| 96 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07309027 |
| 97 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07131412 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06926638 |
| 99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06849080 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06631585 |
| 101 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06515594 |
| 102 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.06313854 |
| 103 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05557943 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05372244 |
| 105 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04931438 |
| 106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04605465 |
| 107 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04192457 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04189018 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03948673 |
| 110 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03766575 |
| 111 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03272973 |
| 112 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01998588 |
| 113 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01998526 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01871206 |
| 115 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01670236 |
| 116 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01383662 |
| 117 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01215204 |
| 118 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01134803 |
| 119 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.00993259 |
| 120 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99473517 |
| 121 | TBL1_22424771_ChIP-Seq_293T_Human | 0.99097279 |
| 122 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98556590 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97506129 |
| 124 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97322756 |
| 125 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.96889952 |
| 126 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95923432 |
| 127 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95560355 |
| 128 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95029604 |
| 129 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95002716 |
| 130 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94585337 |
| 131 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94327270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.41672203 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.64657762 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.14736982 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.11472744 |
| 5 | MP0005171_absent_coat_pigmentation | 3.02965324 |
| 6 | MP0003787_abnormal_imprinting | 3.01825463 |
| 7 | MP0003690_abnormal_glial_cell | 2.86091150 |
| 8 | MP0003195_calcinosis | 2.81421728 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.56605704 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.56595409 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.52489358 |
| 12 | MP0002102_abnormal_ear_morphology | 2.46789403 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.39196950 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.38161005 |
| 15 | MP0003252_abnormal_bile_duct | 2.37094499 |
| 16 | MP0010678_abnormal_skin_adnexa | 2.34270193 |
| 17 | MP0008057_abnormal_DNA_replication | 2.31591053 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.28058980 |
| 19 | MP0002638_abnormal_pupillary_reflex | 2.26269850 |
| 20 | MP0005379_endocrine/exocrine_gland_phen | 2.21310361 |
| 21 | MP0000920_abnormal_myelination | 2.17099678 |
| 22 | MP0000427_abnormal_hair_cycle | 2.14401943 |
| 23 | MP0006054_spinal_hemorrhage | 2.13147139 |
| 24 | MP0002419_abnormal_innate_immunity | 2.05314993 |
| 25 | MP0003283_abnormal_digestive_organ | 2.00471933 |
| 26 | MP0003436_decreased_susceptibility_to | 1.94646876 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.94489009 |
| 28 | MP0006082_CNS_inflammation | 1.83548980 |
| 29 | MP0003303_peritoneal_inflammation | 1.81663889 |
| 30 | MP0005220_abnormal_exocrine_pancreas | 1.79296423 |
| 31 | MP0002163_abnormal_gland_morphology | 1.77438091 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.76320820 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.73835872 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.70129949 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.69702242 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.69628394 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.69125462 |
| 38 | MP0004510_myositis | 1.68171991 |
| 39 | MP0000383_abnormal_hair_follicle | 1.68123540 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.64123477 |
| 41 | MP0004130_abnormal_muscle_cell | 1.63190616 |
| 42 | MP0002938_white_spotting | 1.59795553 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.57974218 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.57378040 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.55839135 |
| 46 | MP0009046_muscle_twitch | 1.55020097 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.54961366 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.54234558 |
| 49 | MP0000604_amyloidosis | 1.52961894 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.52409296 |
| 51 | MP0000516_abnormal_urinary_system | 1.50703622 |
| 52 | MP0005367_renal/urinary_system_phenotyp | 1.50703622 |
| 53 | MP0006072_abnormal_retinal_apoptosis | 1.48511773 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.46650481 |
| 55 | MP0002254_reproductive_system_inflammat | 1.44535237 |
| 56 | MP0005253_abnormal_eye_physiology | 1.44300094 |
| 57 | MP0005085_abnormal_gallbladder_physiolo | 1.43449852 |
| 58 | MP0009840_abnormal_foam_cell | 1.43350823 |
| 59 | MP0003724_increased_susceptibility_to | 1.42067529 |
| 60 | MP0009697_abnormal_copulation | 1.39707031 |
| 61 | MP0005365_abnormal_bile_salt | 1.38033436 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.38018286 |
| 63 | MP0005000_abnormal_immune_tolerance | 1.37594781 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.35516108 |
| 65 | MP0003075_altered_response_to | 1.35324386 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.34883337 |
| 67 | MP0005408_hypopigmentation | 1.31222436 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.30824901 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 1.30313595 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 1.29829530 |
| 71 | MP0000371_diluted_coat_color | 1.26839652 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.26530559 |
| 73 | MP0003950_abnormal_plasma_membrane | 1.24746528 |
| 74 | MP0002095_abnormal_skin_pigmentation | 1.24632305 |
| 75 | MP0004043_abnormal_pH_regulation | 1.20272623 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 1.17705481 |
| 77 | MP0002160_abnormal_reproductive_system | 1.15210063 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 1.15076600 |
| 79 | MP0003633_abnormal_nervous_system | 1.14272280 |
| 80 | MP0001324_abnormal_eye_pigmentation | 1.13685490 |
| 81 | MP0004381_abnormal_hair_follicle | 1.13600603 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.13391226 |
| 83 | MP0000372_irregular_coat_pigmentation | 1.13282109 |
| 84 | MP0005389_reproductive_system_phenotype | 1.13135798 |
| 85 | MP0001851_eye_inflammation | 1.12912199 |
| 86 | MP0003646_muscle_fatigue | 1.12557121 |
| 87 | MP0001756_abnormal_urination | 1.11639289 |
| 88 | MP0002009_preneoplasia | 1.11541335 |
| 89 | MP0001661_extended_life_span | 1.08585159 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 1.08314114 |
| 91 | MP0004484_altered_response_of | 1.06839195 |
| 92 | MP0002452_abnormal_antigen_presenting | 1.06582140 |
| 93 | MP0009764_decreased_sensitivity_to | 1.06195733 |
| 94 | MP0001984_abnormal_olfaction | 1.05936253 |
| 95 | MP0010329_abnormal_lipoprotein_level | 1.04406271 |
| 96 | MP0001501_abnormal_sleep_pattern | 1.03674485 |
| 97 | MP0003045_fibrosis | 1.01959588 |
| 98 | MP0005164_abnormal_response_to | 1.01723653 |
| 99 | MP0000613_abnormal_salivary_gland | 1.01545075 |
| 100 | MP0002928_abnormal_bile_duct | 1.00992633 |
| 101 | MP0003828_pulmonary_edema | 1.00981922 |
| 102 | MP0001986_abnormal_taste_sensitivity | 1.00528686 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.99877423 |
| 104 | MP0001790_abnormal_immune_system | 0.98948454 |
| 105 | MP0005387_immune_system_phenotype | 0.98948454 |
| 106 | MP0003634_abnormal_glial_cell | 0.98922257 |
| 107 | MP0002971_abnormal_brown_adipose | 0.98863104 |
| 108 | MP0003121_genomic_imprinting | 0.98469584 |
| 109 | MP0002933_joint_inflammation | 0.98450675 |
| 110 | MP0005332_abnormal_amino_acid | 0.98240980 |
| 111 | MP0002723_abnormal_immune_serum | 0.95978777 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.95341269 |
| 113 | MP0002090_abnormal_vision | 0.94951069 |
| 114 | MP0005334_abnormal_fat_pad | 0.94412738 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.93272982 |
| 116 | MP0009785_altered_susceptibility_to | 0.93230257 |
| 117 | MP0005360_urolithiasis | 0.93185639 |
| 118 | MP0005310_abnormal_salivary_gland | 0.92820095 |
| 119 | MP0005025_abnormal_response_to | 0.91901481 |
| 120 | MP0003868_abnormal_feces_composition | 0.91165166 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.91117099 |
| 122 | MP0003011_delayed_dark_adaptation | 0.90346788 |
| 123 | MP0000343_altered_response_to | 0.89096042 |
| 124 | MP0002006_tumorigenesis | 0.88392629 |
| 125 | MP0008469_abnormal_protein_level | 0.88346675 |
| 126 | MP0010386_abnormal_urinary_bladder | 0.87295774 |
| 127 | MP0005535_abnormal_body_temperature | 0.86495530 |
| 128 | MP0004134_abnormal_chest_morphology | 0.86223550 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.84252727 |
| 130 | MP0003091_abnormal_cell_migration | 0.83990206 |
| 131 | MP0000609_abnormal_liver_physiology | 0.83986934 |
| 132 | MP0003631_nervous_system_phenotype | 0.83781668 |
| 133 | MP0004215_abnormal_myocardial_fiber | 0.82914140 |
| 134 | MP0005375_adipose_tissue_phenotype | 0.82688246 |
| 135 | MP0003448_altered_tumor_morphology | 0.80907555 |
| 136 | MP0004742_abnormal_vestibular_system | 0.80300009 |
| 137 | MP0005187_abnormal_penis_morphology | 0.79856010 |
| 138 | MP0005386_behavior/neurological_phenoty | 0.78682714 |
| 139 | MP0004924_abnormal_behavior | 0.78682714 |
| 140 | MP0001845_abnormal_inflammatory_respons | 0.78230764 |
| 141 | MP0005388_respiratory_system_phenotype | 0.77294321 |
| 142 | MP0002133_abnormal_respiratory_system | 0.77294321 |
| 143 | MP0000538_abnormal_urinary_bladder | 0.76770155 |
| 144 | MP0005410_abnormal_fertilization | 0.76639851 |
| 145 | MP0005166_decreased_susceptibility_to | 0.76235409 |
| 146 | MP0004885_abnormal_endolymph | 0.75926741 |
| 147 | MP0005670_abnormal_white_adipose | 0.75722097 |
| 148 | MP0009763_increased_sensitivity_to | 0.75592479 |
| 149 | MP0002168_other_aberrant_phenotype | 0.75551212 |
| 150 | MP0008872_abnormal_physiological_respon | 0.75014329 |
| 151 | MP0003632_abnormal_nervous_system | 0.74940087 |
| 152 | MP0002078_abnormal_glucose_homeostasis | 0.74521376 |
| 153 | MP0002166_altered_tumor_susceptibility | 0.74428644 |
| 154 | MP0001177_atelectasis | 0.74089541 |
| 155 | MP0001299_abnormal_eye_distance/ | 0.74027619 |
| 156 | MP0000631_abnormal_neuroendocrine_gland | 0.73642945 |
| 157 | MP0006292_abnormal_olfactory_placode | 0.73420197 |
| 158 | MP0002332_abnormal_exercise_endurance | 0.72762862 |
| 159 | MP0003136_yellow_coat_color | 0.72615808 |
| 160 | MP0006036_abnormal_mitochondrial_physio | 0.69886794 |
| 161 | MP0000639_abnormal_adrenal_gland | 0.69631136 |
| 162 | MP0003943_abnormal_hepatobiliary_system | 0.68647867 |
| 163 | MP0001919_abnormal_reproductive_system | 0.68477424 |
| 164 | MP0005248_abnormal_Harderian_gland | 0.66332437 |
| 165 | MP0005636_abnormal_mineral_homeostasis | 0.64965894 |
| 166 | MP0002075_abnormal_coat/hair_pigmentati | 0.64225073 |
| 167 | MP0003953_abnormal_hormone_level | 0.64199639 |
| 168 | MP0003786_premature_aging | 0.64069616 |
| 169 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63973304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ketoacidosis (HP:0001993) | 4.33847914 |
| 2 | Hypothermia (HP:0002045) | 4.29557209 |
| 3 | Hypoplasia of the fovea (HP:0007750) | 3.86803190 |
| 4 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.86803190 |
| 5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.68862788 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.68474008 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.66084355 |
| 8 | Hypoglycemic seizures (HP:0002173) | 3.51533630 |
| 9 | Myocardial infarction (HP:0001658) | 3.47759058 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.45014625 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.42112122 |
| 12 | Large for gestational age (HP:0001520) | 3.39450325 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.38215839 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.34226012 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.33025292 |
| 16 | Neoplasm of the adrenal cortex (HP:0100641) | 3.32078907 |
| 17 | Abnormality of the fovea (HP:0000493) | 3.21911356 |
| 18 | Hamartoma of the eye (HP:0010568) | 3.15512930 |
| 19 | Albinism (HP:0001022) | 3.15248294 |
| 20 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.08226281 |
| 21 | Thyroiditis (HP:0100646) | 3.04902825 |
| 22 | Joint hemorrhage (HP:0005261) | 3.04394783 |
| 23 | Pancreatic cysts (HP:0001737) | 3.02573871 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.00620555 |
| 25 | Axonal loss (HP:0003447) | 2.99951476 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 2.99654500 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 2.92521156 |
| 28 | Fair hair (HP:0002286) | 2.88172172 |
| 29 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.82718869 |
| 30 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.82601109 |
| 31 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.82601109 |
| 32 | Submucous cleft hard palate (HP:0000176) | 2.80575511 |
| 33 | Abnormality of the renal cortex (HP:0011035) | 2.76834438 |
| 34 | Ketosis (HP:0001946) | 2.76223639 |
| 35 | Generalized hypopigmentation of hair (HP:0011358) | 2.71161343 |
| 36 | Hemiparesis (HP:0001269) | 2.69771390 |
| 37 | Gaze-evoked nystagmus (HP:0000640) | 2.68027219 |
| 38 | Absent frontal sinuses (HP:0002688) | 2.67299440 |
| 39 | Intestinal atresia (HP:0011100) | 2.66528980 |
| 40 | Methylmalonic acidemia (HP:0002912) | 2.66357699 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.66205951 |
| 42 | Hyperventilation (HP:0002883) | 2.63625954 |
| 43 | Tongue fasciculations (HP:0001308) | 2.62611512 |
| 44 | Pancreatic fibrosis (HP:0100732) | 2.60268835 |
| 45 | Hypoplastic ischia (HP:0003175) | 2.59546253 |
| 46 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.58835436 |
| 47 | Conjunctival hamartoma (HP:0100780) | 2.58048536 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.58011018 |
| 49 | Thick nail (HP:0001805) | 2.57427135 |
| 50 | Gingivitis (HP:0000230) | 2.53177238 |
| 51 | Abnormality of vitamin B metabolism (HP:0004340) | 2.45803111 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.45795808 |
| 53 | Polydipsia (HP:0001959) | 2.45750282 |
| 54 | Abnormal drinking behavior (HP:0030082) | 2.45750282 |
| 55 | Aqueductal stenosis (HP:0002410) | 2.45642427 |
| 56 | Gingival bleeding (HP:0000225) | 2.44654563 |
| 57 | Congenital stationary night blindness (HP:0007642) | 2.43884877 |
| 58 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.43784673 |
| 59 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.43784673 |
| 60 | Abnormality of glycolipid metabolism (HP:0010969) | 2.43784673 |
| 61 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.42244417 |
| 62 | Muscle fibrillation (HP:0010546) | 2.35880875 |
| 63 | Epiphyseal dysplasia (HP:0002656) | 2.34412860 |
| 64 | Protuberant abdomen (HP:0001538) | 2.33176476 |
| 65 | Enlarged penis (HP:0000040) | 2.32790911 |
| 66 | Abnormality of the ischium (HP:0003174) | 2.30164984 |
| 67 | Skin nodule (HP:0200036) | 2.30119757 |
| 68 | Blue irides (HP:0000635) | 2.28431382 |
| 69 | Hypomagnesemia (HP:0002917) | 2.28196809 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.27410463 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27310987 |
| 72 | Mucopolysacchariduria (HP:0008155) | 2.27310987 |
| 73 | Abnormal hair whorl (HP:0010721) | 2.26885067 |
| 74 | Xanthomatosis (HP:0000991) | 2.26472365 |
| 75 | Symptomatic seizures (HP:0011145) | 2.26331709 |
| 76 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.25960887 |
| 77 | Nephronophthisis (HP:0000090) | 2.25940759 |
| 78 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.25255252 |
| 79 | Disinhibition (HP:0000734) | 2.24812031 |
| 80 | Prolonged partial thromboplastin time (HP:0003645) | 2.24593704 |
| 81 | Metaphyseal dysplasia (HP:0100255) | 2.23283829 |
| 82 | Intrahepatic cholestasis (HP:0001406) | 2.22244627 |
| 83 | Renal cortical cysts (HP:0000803) | 2.21921689 |
| 84 | Furrowed tongue (HP:0000221) | 2.20542012 |
| 85 | Febrile seizures (HP:0002373) | 2.18699534 |
| 86 | Abnormality of the renal medulla (HP:0100957) | 2.18375833 |
| 87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18078484 |
| 88 | Cutaneous melanoma (HP:0012056) | 2.17850161 |
| 89 | True hermaphroditism (HP:0010459) | 2.17597276 |
| 90 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15799616 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15799616 |
| 92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15799616 |
| 93 | Progressive macrocephaly (HP:0004481) | 2.14271465 |
| 94 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14265747 |
| 95 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.13459310 |
| 96 | Abnormality of midbrain morphology (HP:0002418) | 2.13340733 |
| 97 | Molar tooth sign on MRI (HP:0002419) | 2.13340733 |
| 98 | Abnormality of the frontal sinuses (HP:0002687) | 2.13044539 |
| 99 | Medial flaring of the eyebrow (HP:0010747) | 2.11377805 |
| 100 | Peripheral demyelination (HP:0011096) | 2.11323424 |
| 101 | Stomatitis (HP:0010280) | 2.07366532 |
| 102 | Upper motor neuron abnormality (HP:0002127) | 2.05706939 |
| 103 | Complement deficiency (HP:0004431) | 2.03229725 |
| 104 | Thyroid carcinoma (HP:0002890) | 2.02447779 |
| 105 | Conjugated hyperbilirubinemia (HP:0002908) | 2.02334115 |
| 106 | EEG with generalized epileptiform discharges (HP:0011198) | 2.01473403 |
| 107 | Tubulointerstitial nephritis (HP:0001970) | 2.00723216 |
| 108 | Recurrent skin infections (HP:0001581) | 2.00562758 |
| 109 | Epidermoid cyst (HP:0200040) | 2.00116174 |
| 110 | Breast carcinoma (HP:0003002) | 1.98013498 |
| 111 | Hypercholesterolemia (HP:0003124) | 1.97273419 |
| 112 | Tubular atrophy (HP:0000092) | 1.96673111 |
| 113 | Bell-shaped thorax (HP:0001591) | 1.96492690 |
| 114 | Hematochezia (HP:0002573) | 1.96292787 |
| 115 | Epileptiform EEG discharges (HP:0011182) | 1.95984834 |
| 116 | White forelock (HP:0002211) | 1.95093873 |
| 117 | Hypsarrhythmia (HP:0002521) | 1.94583305 |
| 118 | Retinal atrophy (HP:0001105) | 1.94008877 |
| 119 | Cone-rod dystrophy (HP:0000548) | 1.93811903 |
| 120 | Glomerulonephritis (HP:0000099) | 1.92805573 |
| 121 | Abnormal biliary tract morphology (HP:0012440) | 1.92162028 |
| 122 | Abnormality of the nasal septum (HP:0000419) | 1.91414146 |
| 123 | Patchy hypopigmentation of hair (HP:0011365) | 1.91273929 |
| 124 | Type II lissencephaly (HP:0007260) | 1.91267077 |
| 125 | Prostate neoplasm (HP:0100787) | 1.90593558 |
| 126 | Macroorchidism (HP:0000053) | 1.90471628 |
| 127 | Hyperkalemia (HP:0002153) | 1.90284816 |
| 128 | Generalized hypopigmentation (HP:0007513) | 1.90059913 |
| 129 | Progressive inability to walk (HP:0002505) | 1.89754351 |
| 130 | Abnormal pancreas size (HP:0012094) | 1.88065501 |
| 131 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.86400729 |
| 132 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.86400729 |
| 133 | Disproportionate short-trunk short stature (HP:0003521) | 1.85604624 |
| 134 | Progressive visual loss (HP:0000529) | 1.85201402 |
| 135 | Attenuation of retinal blood vessels (HP:0007843) | 1.84426588 |
| 136 | Neoplasm of the adrenal gland (HP:0100631) | 1.84412770 |
| 137 | Abnormality of incisor morphology (HP:0011063) | 1.84263075 |
| 138 | Methylmalonic aciduria (HP:0012120) | 1.84093640 |
| 139 | Periodontitis (HP:0000704) | 1.84074339 |
| 140 | Mitral stenosis (HP:0001718) | 1.82703485 |
| 141 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80461199 |
| 142 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.80445950 |
| 143 | Optic neuritis (HP:0100653) | 1.80375418 |
| 144 | Retrobulbar optic neuritis (HP:0100654) | 1.80375418 |
| 145 | Excessive salivation (HP:0003781) | 1.80146411 |
| 146 | Drooling (HP:0002307) | 1.80146411 |
| 147 | Vascular calcification (HP:0004934) | 1.79676374 |
| 148 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.79659141 |
| 149 | Downturned corners of mouth (HP:0002714) | 1.78258403 |
| 150 | Cervical subluxation (HP:0003308) | 1.78232044 |
| 151 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.77698450 |
| 152 | Cardiovascular calcification (HP:0011915) | 1.77573496 |
| 153 | Coarse hair (HP:0002208) | 1.76779631 |
| 154 | Increased CSF protein (HP:0002922) | 1.75459427 |
| 155 | Biliary tract neoplasm (HP:0100574) | 1.75305283 |
| 156 | Delayed gross motor development (HP:0002194) | 1.74633919 |
| 157 | Volvulus (HP:0002580) | 1.73942840 |
| 158 | Ovoid vertebral bodies (HP:0003300) | 1.73831146 |
| 159 | Decreased central vision (HP:0007663) | 1.72247283 |
| 160 | Conjunctival telangiectasia (HP:0000524) | 1.72162398 |
| 161 | Hyperglycemia (HP:0003074) | 1.69750124 |
| 162 | Osteolytic defects of the hand bones (HP:0009699) | 1.69169363 |
| 163 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.69169363 |
| 164 | Inappropriate behavior (HP:0000719) | 1.68398501 |
| 165 | Arterial tortuosity (HP:0005116) | 1.68335027 |
| 166 | Calf muscle hypertrophy (HP:0008981) | 1.67962456 |
| 167 | Tetraparesis (HP:0002273) | 1.67692984 |
| 168 | Hypoplasia of the iris (HP:0007676) | 1.67162190 |
| 169 | Curly hair (HP:0002212) | 1.66526877 |
| 170 | Supranuclear gaze palsy (HP:0000605) | 1.65923650 |
| 171 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.65630730 |
| 172 | Clumsiness (HP:0002312) | 1.65446738 |
| 173 | Hypolipoproteinemia (HP:0010981) | 1.65417996 |
| 174 | Hypokinesia (HP:0002375) | 1.64822784 |
| 175 | Generalized myoclonic seizures (HP:0002123) | 1.64740219 |
| 176 | Deep venous thrombosis (HP:0002625) | 1.64405648 |
| 177 | Polyuria (HP:0000103) | 1.63861208 |
| 178 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.62541197 |
| 179 | Cupped ribs (HP:0000887) | 1.62410431 |
| 180 | Widely spaced teeth (HP:0000687) | 1.61799328 |
| 181 | Type I diabetes mellitus (HP:0100651) | 1.61234722 |
| 182 | Absent speech (HP:0001344) | 1.59738503 |
| 183 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.59139509 |
| 184 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.58825137 |
| 185 | Facial diplegia (HP:0001349) | 1.58609098 |
| 186 | Ocular albinism (HP:0001107) | 1.57811675 |
| 187 | Abnormality of the astrocytes (HP:0100707) | 1.57196884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.19982735 |
| 2 | MAP3K14 | 3.14778296 |
| 3 | ACVR1B | 2.95988221 |
| 4 | FRK | 2.92255530 |
| 5 | RIPK4 | 2.66747347 |
| 6 | EIF2AK3 | 2.59832211 |
| 7 | TAOK3 | 2.53881901 |
| 8 | TRPM7 | 2.16929516 |
| 9 | FER | 2.07338077 |
| 10 | PAK3 | 1.98138044 |
| 11 | BMPR2 | 1.73234142 |
| 12 | CAMK1G | 1.71932620 |
| 13 | FGFR2 | 1.71414832 |
| 14 | WNK3 | 1.70254975 |
| 15 | GRK1 | 1.68128533 |
| 16 | EPHB1 | 1.65571131 |
| 17 | NLK | 1.57116940 |
| 18 | BRSK2 | 1.55324423 |
| 19 | PTK2B | 1.51762614 |
| 20 | IRAK4 | 1.50798782 |
| 21 | JAK1 | 1.50135127 |
| 22 | IRAK3 | 1.49220050 |
| 23 | TRIM28 | 1.47784650 |
| 24 | TNIK | 1.46889693 |
| 25 | MKNK2 | 1.45795111 |
| 26 | ERBB3 | 1.44620746 |
| 27 | MAP3K2 | 1.42228352 |
| 28 | STK38L | 1.41591098 |
| 29 | CAMK1D | 1.41384921 |
| 30 | PBK | 1.39790468 |
| 31 | PKN1 | 1.37890659 |
| 32 | MAP4K2 | 1.33571061 |
| 33 | MAPK13 | 1.33133206 |
| 34 | PHKG2 | 1.32322148 |
| 35 | PHKG1 | 1.32322148 |
| 36 | ADRBK2 | 1.30957811 |
| 37 | STK39 | 1.28630900 |
| 38 | WNK1 | 1.24576823 |
| 39 | EIF2AK1 | 1.18020480 |
| 40 | YES1 | 1.17944970 |
| 41 | MAP3K13 | 1.16467647 |
| 42 | MAP3K4 | 1.16097429 |
| 43 | NUAK1 | 1.15000789 |
| 44 | EPHA3 | 1.14180754 |
| 45 | FGFR3 | 1.11659793 |
| 46 | MET | 1.10561446 |
| 47 | JAK3 | 1.08551080 |
| 48 | PDGFRB | 1.07995822 |
| 49 | TTN | 1.07254083 |
| 50 | MST1R | 1.06361035 |
| 51 | PINK1 | 1.04785357 |
| 52 | STK24 | 1.04095366 |
| 53 | IKBKB | 1.01084661 |
| 54 | SGK2 | 0.99330074 |
| 55 | NTRK3 | 0.98243032 |
| 56 | PDK2 | 0.97351569 |
| 57 | TGFBR2 | 0.96817156 |
| 58 | SGK3 | 0.96277253 |
| 59 | TBK1 | 0.95200975 |
| 60 | CSNK1G1 | 0.94877953 |
| 61 | ERBB4 | 0.94226177 |
| 62 | FGR | 0.92917644 |
| 63 | PRKAA2 | 0.92288644 |
| 64 | PLK2 | 0.92076139 |
| 65 | CHUK | 0.91255231 |
| 66 | TYK2 | 0.91174725 |
| 67 | GRK7 | 0.86042668 |
| 68 | MAPK7 | 0.85272240 |
| 69 | SGK1 | 0.85008497 |
| 70 | NEK6 | 0.84686081 |
| 71 | DMPK | 0.83054545 |
| 72 | MAPK15 | 0.81389590 |
| 73 | DAPK2 | 0.80613691 |
| 74 | MARK3 | 0.80539782 |
| 75 | BMX | 0.80494563 |
| 76 | JAK2 | 0.80311884 |
| 77 | NEK9 | 0.80141986 |
| 78 | PIK3CA | 0.79863302 |
| 79 | IRAK1 | 0.79637732 |
| 80 | AKT3 | 0.78793978 |
| 81 | STK3 | 0.77791831 |
| 82 | PRKCQ | 0.77285935 |
| 83 | IKBKE | 0.77065313 |
| 84 | TXK | 0.76658401 |
| 85 | CSNK1G2 | 0.75958532 |
| 86 | OBSCN | 0.74739654 |
| 87 | HCK | 0.74427370 |
| 88 | PDK1 | 0.73984642 |
| 89 | PLK3 | 0.72611130 |
| 90 | LATS1 | 0.71739947 |
| 91 | PRKCE | 0.71264866 |
| 92 | SGK223 | 0.71015406 |
| 93 | SGK494 | 0.71015406 |
| 94 | WNK4 | 0.70693295 |
| 95 | KIT | 0.70264390 |
| 96 | PDPK1 | 0.69937811 |
| 97 | BMPR1B | 0.69630335 |
| 98 | CASK | 0.69358265 |
| 99 | PIK3CG | 0.66013356 |
| 100 | MAP3K3 | 0.65742483 |
| 101 | HIPK2 | 0.64660621 |
| 102 | OXSR1 | 0.62613140 |
| 103 | CSK | 0.61804377 |
| 104 | CAMKK2 | 0.61619904 |
| 105 | SCYL2 | 0.61526943 |
| 106 | PRKAA1 | 0.61216058 |
| 107 | CSNK1G3 | 0.60323793 |
| 108 | ADRBK1 | 0.60213777 |
| 109 | MAP3K6 | 0.59968100 |
| 110 | RET | 0.58745423 |
| 111 | ABL1 | 0.58018079 |
| 112 | DDR2 | 0.57234624 |
| 113 | CAMK2D | 0.57189788 |
| 114 | STK11 | 0.56674641 |
| 115 | LCK | 0.56362868 |
| 116 | PRPF4B | 0.55999398 |
| 117 | TEC | 0.55926610 |
| 118 | MST4 | 0.55623332 |
| 119 | CSNK1A1L | 0.54540523 |
| 120 | CSF1R | 0.53534356 |
| 121 | CLK1 | 0.53009365 |
| 122 | ITK | 0.52902449 |
| 123 | GSK3A | 0.52227237 |
| 124 | IRAK2 | 0.50919083 |
| 125 | EGFR | 0.49733407 |
| 126 | MKNK1 | 0.49653944 |
| 127 | MAP2K1 | 0.49459079 |
| 128 | IGF1R | 0.49353072 |
| 129 | PRKG1 | 0.48457780 |
| 130 | BCR | 0.48282538 |
| 131 | FES | 0.47126213 |
| 132 | WEE1 | 0.46987843 |
| 133 | LYN | 0.46728535 |
| 134 | PRKCH | 0.43730332 |
| 135 | PRKCI | 0.43606632 |
| 136 | PNCK | 0.43460481 |
| 137 | PDK4 | 0.42400040 |
| 138 | PDK3 | 0.42400040 |
| 139 | EPHA4 | 0.42061211 |
| 140 | MAP3K12 | 0.39302245 |
| 141 | KSR1 | 0.35963500 |
| 142 | ZAK | 0.34085709 |
| 143 | MAP2K6 | 0.31924394 |
| 144 | MELK | 0.31514555 |
| 145 | PRKCG | 0.29657462 |
| 146 | MAPKAPK3 | 0.29263437 |
| 147 | ROCK1 | 0.28826112 |
| 148 | CSNK1D | 0.28304309 |
| 149 | MUSK | 0.27346262 |
| 150 | CAMK2A | 0.26345759 |
| 151 | RPS6KB1 | 0.26269680 |
| 152 | ATM | 0.25214600 |
| 153 | MAP2K7 | 0.25098369 |
| 154 | CDK3 | 0.24828191 |
| 155 | EIF2AK2 | 0.24026939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.05141891 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.55032567 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.27793343 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.13597409 |
| 5 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.91090139 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89698227 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 1.88168281 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 1.81432561 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 1.76850837 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.69236606 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.68829296 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.65603769 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62439456 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60501164 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.51156514 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46166885 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39578216 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.34595082 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34432041 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.33209175 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31390930 |
| 22 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29189130 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29110292 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28868938 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.28705389 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25654439 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25594134 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.21455125 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20775142 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19805577 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19425757 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.18805134 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16623500 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14968293 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.14184232 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12732724 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12072008 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11274584 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09989105 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08200461 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07655424 |
| 42 | RNA degradation_Homo sapiens_hsa03018 | 1.05315514 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.03642301 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03303397 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.02416177 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02272854 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98339726 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97795809 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94500453 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94005889 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93207018 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91891247 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88123688 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87639677 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86856380 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86705483 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.86200510 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.85925653 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84563436 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81946064 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81813233 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.81029845 |
| 63 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80499888 |
| 64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79189032 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79060156 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78967245 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76933349 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.76438833 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71361850 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.69607777 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.67629701 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67556128 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.67411715 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65979231 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65226819 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63558079 |
| 77 | Salivary secretion_Homo sapiens_hsa04970 | 0.63338394 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.62827478 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62612678 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.61997152 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.61458064 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61455016 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59888064 |
| 84 | Allograft rejection_Homo sapiens_hsa05330 | 0.58415441 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.58134080 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56951263 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56626176 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56175117 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55983028 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.55952611 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55902957 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55698747 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55593339 |
| 94 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55390584 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.55202729 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55030117 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54299206 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54060117 |
| 99 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.53828760 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53460383 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53174514 |
| 102 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52853682 |
| 103 | Long-term depression_Homo sapiens_hsa04730 | 0.52426583 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.51971134 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50119318 |
| 106 | Measles_Homo sapiens_hsa05162 | 0.49925952 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49683464 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49594452 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.49533491 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49520047 |
| 111 | Melanoma_Homo sapiens_hsa05218 | 0.49484663 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49428058 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48834988 |
| 114 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48777426 |
| 115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48256608 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46724157 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46338611 |
| 118 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45714025 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.45345081 |
| 120 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45104003 |
| 121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44826752 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.44658050 |
| 123 | Homologous recombination_Homo sapiens_hsa03440 | 0.44446137 |
| 124 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44227039 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44214360 |
| 126 | Asthma_Homo sapiens_hsa05310 | 0.43592106 |
| 127 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43546945 |
| 128 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42776912 |
| 129 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.42398849 |
| 130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42312418 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42302229 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | 0.41816221 |
| 133 | Prion diseases_Homo sapiens_hsa05020 | 0.41653153 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40953857 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40907469 |
| 136 | Insulin secretion_Homo sapiens_hsa04911 | 0.40664701 |
| 137 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40596361 |
| 138 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40419068 |
| 139 | Taste transduction_Homo sapiens_hsa04742 | 0.39178000 |
| 140 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38636085 |
| 141 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.33921231 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33053071 |
| 143 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32099312 |
| 144 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30652224 |
| 145 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30411827 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30154435 |

